STOCK TITAN
  1. Home
  2. Sec-filings
  3. AKTX
  4. [Form 4] Akari Therapeutics Plc Insider Trading Activity

Akari Therapeutics (AKTX) interim CFO granted new ADS awards

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Farag Kameel D. reported acquisition or exercise transactions in this Form 4 filing.

Akari Therapeutics Plc interim CFO Farag Kameel D. received share awards in the form of American Depositary Shares (ADSs) representing ordinary shares. On June 24, 2026, multiple grant/award transactions (code A) increased his direct ADS holdings to 20,452 shares.

A footnote explains these ADS-related awards represent restricted stock units (RSUs), with each RSU giving the right to receive 80,000 ordinary shares. The RSUs vested in full on June 24, 2026, indicating these grants are compensation-related rather than open‑market purchases.

Positive

  • None.

Negative

  • None.
Insider Farag Kameel D.
Role Interim CFO
Type Security Shares Price Value
Grant/Award American Depositary Shares representing Ordinary Shares 1,248 $10.02 $13K
Grant/Award American Depositary Shares representing Ordinary Shares 1,395 $9.32 $13K
Grant/Award American Depositary Shares representing Ordinary Shares 1,570 $8.28 $13K
Grant/Award American Depositary Shares representing Ordinary Shares 2,539 $5.12 $13K
Grant/Award American Depositary Shares representing Ordinary Shares 3,725 $3.49 $13K
Grant/Award American Depositary Shares representing Ordinary Shares 7,353 $3.74 $28K
Grant/Award American Depositary Shares representing Ordinary Shares 1,000 $13.00 $13K
Holdings After Transaction: American Depositary Shares representing Ordinary Shares — 2,870 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Post-transaction holdings 20,452 ADS Direct holdings after June 24, 2026 grants
Grant example 1,000 ADS at $13.00 Grant/award acquisition on June 24, 2026
Grant example 7,353 ADS at $3.74 Grant/award acquisition on June 24, 2026
RSU ordinary share right 80,000 ordinary shares per RSU Footnote describing RSU structure
Transaction count 7 acquisitions All coded A as grant/award on June 24, 2026
Vesting date June 24, 2026 RSUs vested in full on this date
American Depositary Shares financial
"These American Depositary Shares represent restricted stock units ("RSUs")"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
restricted stock units ("RSUs") financial
"These American Depositary Shares represent restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
par value financial
"ordinary shares with a par value of $0.000000005 per ordinary share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Farag Kameel D.
(Last)(First)(Middle)
C/O AKARI THERAPEUTICS PLC
401 EAST JACKSON STREET, SUITE 3300
(Street)
TAMPA FLORIDA 33602
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Akari Therapeutics Plc [ AKTX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Interim CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
American Depositary Shares representing Ordinary Shares06/24/2026A1,248(1)A$10.022,870D
American Depositary Shares representing Ordinary Shares06/24/2026A1,395(1)A$9.324,265D
American Depositary Shares representing Ordinary Shares06/24/2026A1,570(1)A$8.285,835D
American Depositary Shares representing Ordinary Shares06/24/2026A2,539(1)A$5.128,374D
American Depositary Shares representing Ordinary Shares06/24/2026A3,725(1)A$3.4912,099D
American Depositary Shares representing Ordinary Shares06/24/2026A7,353(1)A$3.7419,452D
American Depositary Shares representing Ordinary Shares06/24/2026A1,000(1)A$1320,452D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026.
/s/ Abizer Gaslightwala, as Attorney-in-Fact06/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR